Artificial intelligence (AI) is revolutionizing drug discovery and development, with many AI-developed drugs currently in clinical trials. Researchers caution that while AI is accelerating the process, it is still in its early stages. Google DeepMind CEO predicts AI-made prescription drugs will be ready for clinical trials in a couple of years. Scientists have created a 'self-driving' lab using AI for in-depth analyses of catalytic reactions in chemical research and pharmaceutical manufacturing.
#AI-developed drugs have to be tested in #clinicaltrials, so their time to market will be the same as other #drugs https://t.co/THKAjhCf7T
Scientists say they have developed a “self-driving” lab that uses artificial intelligence (AI) and automated systems to provide in-depth analyses of catalytic reactions used in chemical research and pharmaceutical manufacturing. Learn more: https://t.co/IqD1wx33bS https://t.co/tOr22iOURz
Interested in the concept—though realizing it, especially with human data, hints at a long journey ahead. It reminds me of Genelogic's early work in toxicogenomics, albeit with a modern update: today's multimodal AI, enhanced in vitro models, and rapid data generation methods. https://t.co/a9WPoQJJ7k
Many drugs developed with AI’s help are currently in clinical trials. https://t.co/599TBBWJKw
Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO https://t.co/pCF9kf9bvU
AI is speeding up drug discovery and development, but the technology is still in its early days, researchers caution. https://t.co/599TBBWJKw